Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways

Clinical and Investigative Medicine

Volumn 32, Issue 1, 2009, Pages

  Ye, Zeng Chun ^a   Wang, Cheng ^a   Tang, Ying ^b   Liu, Xun ^a   Peng, Hui ^a   Zhang, Hui ^c   Lou, Tan Qi ^a,b  

^a 3rd Affiliated Hospital   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; BETA N ACETYLHEXOSAMINIDASE; IMMUNOGLOBULIN A1; INTEGRIN LINKED KINASE; JACALIN; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VALSARTAN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; MESANGIUM CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL ADHESION; CULTURE MEDIA; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; MICE; PODOCYTES; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 59649112183     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Van Der Boog PJ, Van Kooten C, De Fijter JW, et al. Role of macromolecular IgA in IgA nephropathy. Kidney Int 2005; 67:813-21
2. Nartia I, Gejyo F. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy. Clin Exp Nephrol 2008; 12:332-8
3. Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA Nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007; 71: 1148-54
4. Ding JX, Xu LX, Lv JC, et al. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy. Clin Immunol 2007 ; 125: 268-74
5. Lai KN, Tang SC, Guh JY, et al. Polymeric IgA1 from patients with IgA nephropathy upregulates TGF-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 2003; 14: 3127-37
6. Loretta Y.Y. Chan, Joseph C.K, Antia W.L. et al. Activation of tubular epithelial cells by mesangial-derived TNF-α: Glomerulotubular communication in IgA nephropathy. Kidney Int 2005; 67:602-12
7. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 2004; 136:168-75
8. Diven SC, Caflisch CR, Hammond DK, Weigel PH, Oka JA, Goldblum RM. IgA induced activation of human mesangial cells: independent of FcalphaR1 (CD 89). Kidney Int 1998; 54:837-47
9. Lemley KV, Lafayette RA, Safai M, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61: 475-85
10. Shanklang SJ. The podocyte's response to injury: role in proteinuria and glomerulo sclerosis. Kidney Int 2006; 69: 2131-47
11. Petermann AT, Krofft R, Blonski M, et al. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int 2003; 64 : 1222-31
12. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285: F40-F48
13. Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 2002 ; 57: 247-53
14. Kretzler M, Teixeira VPC, Unschuld PG, et al. Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J 2001; 15:1843-5
15. Wang CH, Peng H, Tang H, et al. Serum IgA1 from IgA nephropathy induces apoptosis in podocytes through direct and indirect pathway. Clin Invest Med 2007; 30: E240-E249.
16. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 1984;67:379-88.
17. Lai KN, Leung JC, Chan LY, et al. Activation of podocyte by mesangial-derived TNF-α: glomerulo-podocytic communication in IgA Nephropathy. Am J Physiol Renal Physiol 2008;294: F945-55.
18. Donghaiyu, Arndt Petermann, Utaketer, et al. Urinary podocytes loss is more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005;16:1733-40.
19. Masanori Hara, Toshio Yanagihara, Itaru Kihara. Culmulative excretion of urinary podocytes reflects disease progression in IgA nephropathy. Clin J Am Soc Nephrol 2007;2:231-8.
20. Teixeira VPC, Blattner SM, Li M, et al. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005;67:514-23.
21. Guo L, Sanders PW, Woods A, Wu C. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 2001;159:1735-42
22. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 1996;379:91-6
23. Wu C, Dedhar S. Integrin linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001;155:505-510
24. Chie Miyake-Ogawa, Masanobu Miyazaki, Katsushige Abe, et al. Tissue-Specific Expression of Renin-Angiotensin System Components in IgA Nephropathy. Am J Nephrol 2005;25:1-12
25. Han SY, Kang YS, Jee YH, et al. High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes. Cell Tissue Res 2006;323:321-32